Rhegmatogenous retinal detachments in HIV-positive patients with ocular syphilis.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Rhegmatogenous retinal detachments in HIV-positive patients with ocular syphilis.

Ophthalmic Surg Lasers. 1996 Aug;27(8):699-705. Unique Identifier : AIDSLINE MED/97011626
Williams JK; Kirsch LS; Russack V; Freeman WR; Department of Ophthalmology, University of California at San; Diego, La Jolla 92093-0946, USA.

Abstract: The purpose of this study is to report retinal manifestations of lues in human immunodeficiency virus (HIV)-positive patients and to suggest a method for treatment of rhegmatogenous retinal detachments in these patients. Two HIV-positive patients with bilateral retinitis were examined and treated at the authors' institution for a period of 14 months. Ocular syphilis was diagnosed clinically, confirmed by cerebrospinal fluid serologic testing, and treated with intravenous penicillin. Both patients experienced bilateral rhegmatogenous retinal detachments complicated by proliferative vitreoretinopathy after resolution of the active retinitis. All four eyes underwent surgical repair with trans pars plana vitrectomy, epiretinal membrane delamination, gas-fluid exchange, endolaser, scleral buckle, and silicone oil instillation. The recognition of ocular syphilis as a cause of retinal detachment in HIV-positive patients is important. Prompt intervention with the appropriate medical and surgical treatments may result in the preservation of vision in these patients.

Keywords: Adult Case Report Eye Infections, Bacterial/*COMPLICATIONS/DRUG THERAPY Female Fluorescein Angiography Follow-Up Studies Fundus Oculi Human HIV Seropositivity/*COMPLICATIONS *HIV-1 Male Penicillin G/THERAPEUTIC USE Penicillins/THERAPEUTIC USE Retinal Detachment/*ETIOLOGY/PATHOLOGY/SURGERY Retinitis/DRUG THERAPY/*MICROBIOLOGY Syphilis/*COMPLICATIONS/DRUG THERAPY Syphilis Serodiagnosis Visual Acuity Vitreoretinopathy, Proliferative/ETIOLOGY/SURGERY JOURNAL ARTICLE
970228
M9721927

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .